SureTrader
Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Board Catalyst and Chart Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
 
Followed By 472
Posts 76,651
Boards Moderated 3
Alias Born 03/31/08
160x600 placeholder
China Stocks In Focus After Ringing In 'Year Of The Monkey'
Hong Kong selloffs provide sneak peek of what might be in store While U.S. traders enjoy the President's Day holiday on Monday,...
Top Equities Stories Of The Day
Facebook Executive In India Steps Down
Last Wave on Libor: CFTC Likely to Charge Multiple Banks for Rate Rigging
Morgan Stanley In $3.2 Billion Settlement
U.S. Judge Questions Regulators on MetLife Designation
Apple Developing TV Series to Bolster Subscription Music Service
Chesapeake Says It Doesn't Plan to Pursue Bankruptcy -- 2nd Update
J.P. Morgan CEO Buys 500,000 of Bank's Shares -- Update
CFPB Presses Banks, Credit Unions to Offer 'Small-Dollar Loans'
dDT   Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 83010 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist